Gender differences in antithrombotic treatment in patients with atrial fibrillation from Spain versus the rest of Western Europe. GLORIA-AF Program — José López‐Sendón (2021) | RDL Network
Gender differences in antithrombotic treatment in patients with atrial fibrillation from Spain versus the rest of Western Europe. GLORIA-AF Program
Article 2021 en
Authors
JL
José López‐Sendón
DA
David Alonso‐Rodríguez
GB
Gonzalo Barón‐Esquivias
Abstract
1 min read
OAC rates were higher in Spain as compared to rWE. More women received OACs in Spain, while in rWE no difference by gender was observed. DOACs in rWE are the most prescribed OAC while in Spain, due to prescription barriers, its use remains low for both genders and VKAs are preferred. Spanish women received more DOACs compared to men. (NCT01468701).
José López‐Sendón, David Alonso‐Rodríguez, Gonzalo Barón‐Esquivias, Juan Cosı́n-Sales, Francisco Marı́n, Jordi Galera-Llorca, Natalia de las Heras, Sabrina Marler, Menno V. Huisman, Professor Gregory Lip
Valeria Caso, Maurizio Paciaroni, Giancarlo Agnelli, Francesco Corea, Walter Ageno, Andrea Alberti, Alessia Lanari, Sara Micheli, Luca Bertolani, Michele Venti, Francesco Palmerini, Antonia M.R. Billeci, Gıancarlo Comı, Paolo Previdi, Giorgio Silvestrelli
Discussion(0)
No comments yet. Be the first to comment.